Your Article Summary
Covidien Receives FDA Clearance for its Mallinckrodt(TM) TaperGuard(TM) Evac Endotracheal Tube
Covidien, 10/01/09
Covidien, a leading global provider of healthcare products and recognized innovator in mechanical ventilation and respiratory care devices, announced that it has received 510(k) clearance from the U.S. Food and Drug Administration to market its Mallinckrodt(TM) TaperGuard(TM) Evac endotracheal tube. The TaperGuard endotracheal tube reduces leakage past the cuff by at least 81%, compared with the Mallinckrodt Hi–Lo(TM) endotracheal tube1, potentially reducing the risk of postsurgical complications that may be caused by aspiration of fluids into the lungs.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
FDA Approves Gardasil to Prevent Genital Warts in Males. Agency Also Approves Bivalent HPV Vaccine for Girls, Young Women
American Family Physician, 10/27/09
Novartis receives FDA approval for Valturna®, a single-pill combination of valsartan and aliskiren, to treat high blood pressure
Novartis, 09/18/09
Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09
Today in Marketing/Media/ROI...keeping you current
Receive free subspecialty "5-minute updates" via email
Salix Receives FDA Marketing Approval for Metozolv
Salix Pharmaceuticals, 09/09/09
Nabi Biopharmaceuticals Completes Sale of PentaStaph to GlaxoSmithKline PLC
Nabi Biopharmaceuticals, 11/05/09
Shire Reports Tolerability and Clinical Effects Results of DAYTRANA from Study in Adolescents with ADHD
Shire, 11/02/09
Article Search
Sponsor


See Latest Articles


